🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study compares haplo-identical family donor stem cell transplantation ...
Status
Terminated
Location
Medical University of Vienna
Start Date
2019-11-12
Trial ID
NCT04067180
The goal of this clinical research study is to learn if giving romidepsin b...
Status
Completed
Location
The Ohio State University Cancer Center
Start Date
2017-12-08
Trial ID
NCT02512497
Treatments Being Tested
This is a single-arm, open label, phase 2 study to determine the safety and...
Status
Not Yet Recruiting
Location
University of Michigan
Start Date
2026-07
Trial ID
NCT06995521
Treatments Being Tested
The immune system has offensive and defensive capacities. In bone marrow tr...
Status
Terminated
Location
Katholieke Universiteit Leuven
Start Date
2013-07
Trial ID
NCT01903473
Treatments Being Tested
The study seeks to compare time from formal search to hematopoietic cell tr...
Status
Terminated
Location
University of Chicago Cancer Center
Start Date
2016-02-04
Trial ID
NCT02648932
Treatments Being Tested
This phase II trial investigates how well a naive T cell depleted graft wor...
Status
Not Yet Recruiting
Location
Seattle Children's Hospital
Start Date
2026-09
Trial ID
NCT07660783
Treatments Being Tested
RATIONALE: Giving low doses of chemotherapy, such as melphalan and fludarab...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2001-07
Trial ID
NCT00027560
RATIONALE: Rasburicase may be an effective treatment for graft-versus-host ...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2008-01
Trial ID
NCT00513474
This phase II trial studies the side effects and best dose of iodine I 131 ...
Status
Terminated
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2003-05
Trial ID
NCT00119366
The goal of this clinical research study is to learn if adding Zevalin (ibr...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2013-01
Trial ID
NCT01490723